Showing 1451-1460 of 1676 results for "".
- Asepticys Files 510k Submission With FDA for TriFlect Disinfection Technologyhttps://modernod.com/news/asepticys-files-510k-submission-with-fda-for-triflect-disinfection-technology/2476450/Asepticys announced the completion of multisite human clinical trials for Asepticys’ novel contact lens care solution containing TriFlect technology. The company has submitted a 510(k) application to the FDA. The clinical trials involved over 320 patients at 12 sites across
- Zeiss Receives FDA Clearance for Epithelial Thickness Mapping for CIRRUS HD-OCThttps://modernod.com/news/zeiss-receives-fda-clearance-for-epithelial-thickness-mapping-for-cirrus-hd-oct/2476359/Zeiss announced that it has received FDA 510(k) clearance for the CIRRUS HD-OCT platform, expanding the capabilities of its Anterior Segment Premier Module to include epithelial thickness mapping (ETM). According to refractive specialist John Doane, MD, of Discover Vision Center in Kansas
- Bausch + Lomb Receives FDA Clearance For Ultra Multifocal For Astigmatism Contact Lenseshttps://modernod.com/news/bausch-lomb-receives-fda-clearance-for-ultra-multifocal-for-astigmatism-contact-lenses/2476156/Bausch + Lomb announced that it has received FDA 510(k) clearance for Bausch + Lomb Ultra Multifocal for Astigmatism contact lenses, the company’s first multifocal toric lens to be available as a standard offering. Bausch + Lomb says the monthly silicone hydrogel lens is the company&
- Former P&G And Cincinnati Children’s Executive Katherine Overbey Joins OneSight As President And Executive Directorhttps://modernod.com/news/former-pg-and-cincinnati-childrens-executive-katherine-overbey-joins-onesight-as-president-and-executive-director/2480057/Global vision care nonprofit OneSight announced that Katherine “K-T” Overbey will be joining the organization as President and Executive Director. Ms. Overbey brings a distinct blend of blue-chip corporate and nonprofit experience in both developed and emerging markets, as well as a s
- Optovue Announces Expanded FDA Clearance of Epithelial Thickness Mappinghttps://modernod.com/news/optovue-announces-expanded-fda-clearance-of-epithelial-thickness-mapping/2480088/Optovue announced an expanded FDA 510(k) clearance for non-contact, quantitative measurements of the epithelial and stromal layers of the cornea, termed epithelial thickness mapping (ETM). The expanded clearance adds a 9-millimeter ETM scan to the previously available 6-millimeter map, allowing f
- Nexy Robotic Retinal Imaging System Receives FDA Clearancehttps://modernod.com/news/nexy-robotic-retinal-imaging-system-receive-fda-clearance/2480097/Konan Medical USA announced that the Nexy retinal camera received FDA 510(k) clearance and is now available in the United States. The Nexy features fully robotic operation and is designed for use in ophthalmology, optometry, hospitals, clinics and many other point-of-servic
- Optovue Receives FDA Clearance for AngioAnalytics – the First OCT Angiography Metrics Technologyhttps://modernod.com/news/optovue-receives-fda-clearance-for-angioanalytics-the-first-oct-angiography-metrics-technology/2480103/Optovue announced FDA 510(k) clearance of AngioAnalytics, the first optical coherence tomography angiography (OCTA) blood vessel measurement technology to help clinicians manage diseases that cause progressive blindness. The company also received clearance for its three-dimensional projection art
- Lensar Laser System Receives FDA Clearance to Perform Corneal Pockets and Flaps for Corneal Inlay Procedureshttps://modernod.com/news/lensar-laser-system-receives-fda-clearance-to-perform-corneal-pockets-and-flaps-for-corneal-inlay-procedures/2480258/Lensar announced it has received 510(k) clearance from the FDA for the Lensar Laser System with Streamline IV, expanding the platform’s capabilities to include the creation of the corneal pockets and flaps used in ophthalmic procedures treating presbyopia. With the new indications, the Len
- CIRM Awards $4.7 Million for Vision Loss Gene Therapyhttps://modernod.com/news/cirm-awards-47-million-for-vision-loss-gene-therapy/2482827/The California Institute for Regenerative Medicine (CIRM) awarded $4.7 million to Blue Gen Therapeutics Foundation (Principal Investigator Aaron Nagiel, MD, PhD) to fund preclinical research that aims to develop a gene therapy for the rare disease blue cone monochromacy (BCM). <
- Rayner Completes Recruitment for RayOne Galaxy IDE Studyhttps://modernod.com/news/rayner-completes-recruitment-for-rayone-galaxy-ide-study/2482642/Rayner announced the closure of recruitment in the Investigational Device Exemption (IDE) study for the RayOne Galaxy IOL in the United States. Developed in collaboration with Brazilian ophthalmologist João Lyra, MD, PhD, RayOne Galaxy is the worl